RMD Resmed Earnings and EPS analysis

EPS in 2026 (TTM): $10.4

Last Report Period Date: Mar 31, 2026

Currently, RMD's 12-month EPS stands at $10.4, according to the most recent financial reports. Resmed's earnings per share in 2025 was reported at $9.55, marking a rise from $6.94 in 2024. RMD recorded an EPS of $2.74 for the quarterly period ending on Mar 31, 2026.

In 2025, Resmed's earnings per share was $9.55, a rise of 37.6% from $6.94 in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was $2.74, showing a 10% increase compared to the same quarter last year. The trailing twelve months EPS for RMD is $10.4 as of March 2026. Resmed's full-year EPS for 2024 was $6.94, a 13.4% rise compared to the previous year.

Resmed has recorded a growth in earnings per share of 10% over the past 12 months (YoY, quarterly). During the past three years, RMD had an average yearly EPS growth of 21.4%. Resmed had an average annual EPS growth of 17.2% in the last five years. Over the last decade, RMD had an average annual earnings per share growth of 14.3%.